Collaborative Research Development Grant

The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.

Funding Information

• Support of up to $300,000USD annually for three years ($900,000USD total) will be granted to the institution(s) in which the recipients will conduct the research. CRDGs have an anticipated start date of January 1, 2025.

Eligibility Criteria

• The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility. They should not currently be in a training program. At least one key investigator must be a physician with expertise on ovarian cancer. International collaborations are welcome.
• The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics. Submissions that focus on health services research, quality of life, and epidemiology are also encouraged. Proposed projects should focus on ovarian cancers and/or related gynecologic cancers.
• The primary review criteria will be the likelihood that the investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding.
• International applicants are welcome to apply.

For more information, visit OCRA.